OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A review of drug-drug interactions in older HIV-infected patients
Aarthi Chary, Nancy N. Nguyen, Kimberly Maiton, et al.
Expert Review of Clinical Pharmacology (2017) Vol. 10, Iss. 12, pp. 1329-1352
Closed Access | Times Cited: 21

Showing 21 citing articles:

Polypharmacy and Drug–Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study
Beatriz López Centeno, Carlos Badenes-Olmedo, Angel Mataix-San-Juan, et al.
Clinical Infectious Diseases (2019) Vol. 71, Iss. 2, pp. 353-362
Open Access | Times Cited: 68

Drug‐drug interactions with candidate medications used for COVID‐19 treatment: An overview
Haleh Rezaee, Fariba Pourkarim, Samira Pourtaghi‐Anvarian, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 37

Headache in transgender and gender‐diverse patients: A narrative review
Jennifer A. Hranilovich, Eric A. Kaiser, Anna Pace, et al.
Headache The Journal of Head and Face Pain (2021) Vol. 61, Iss. 7, pp. 1040-1050
Closed Access | Times Cited: 33

Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
Dario Cattaneo, Luca Pasina, Aldo P. Maggioni, et al.
Drugs & Aging (2020) Vol. 37, Iss. 12, pp. 925-933
Open Access | Times Cited: 31

Prescribing issues in elderly individuals living with HIV
Catia Marzolini, Françoise Livio
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 7, pp. 643-659
Closed Access | Times Cited: 29

Contemporary Drug–Drug Interactions in HIV Treatment
Aaron S. Devanathan, Daijha J.C. Anderson, Mackenzie L. Cottrell, et al.
Clinical Pharmacology & Therapeutics (2019) Vol. 105, Iss. 6, pp. 1362-1377
Closed Access | Times Cited: 28

Cushing’s syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case–control study in the French Pharmacovigilance Database
Laure Peyro‐Saint‐Paul, Paul Besnier, Ludivine Demessine, et al.
Journal of Antimicrobial Chemotherapy (2019) Vol. 74, Iss. 11, pp. 3291-3294
Closed Access | Times Cited: 26

Challenges of HIV Management in an Aging Population
Alvin G. Thomas, Jennifer Hoy
Current HIV/AIDS Reports (2024) Vol. 22, Iss. 1
Closed Access | Times Cited: 2

A patient-centred approach to deprescribing antiretroviral therapy in people living with HIV
Giovanni Guaraldi, Jovana Milić, Simone Marcotullio, et al.
Journal of Antimicrobial Chemotherapy (2020) Vol. 75, Iss. 12, pp. 3425-3432
Open Access | Times Cited: 15

Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria
Ernest Ekong, Nicaise Ndembi, Prosper Okonkwo, et al.
AIDS Research and Therapy (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 13

Pharmacokinetics of Antiretroviral Drugs in Older People Living with HIV: A Systematic Review
Thainá Toledo, Thales Nascimento Castro, Vanessa G. Oliveira, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 9, pp. 1219-1230
Closed Access | Times Cited: 4

An update on drug–drug interactions in older adults living with human immunodeficiency virus (HIV)
Rebecca Y. Linfield, Nancy N. Nguyen, Olivia H. Laprade, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 7, pp. 589-614
Closed Access | Times Cited: 1

Short Communication: Getting Older with HIV: Increasing Frequency of Comorbidities and Polypharmacy in Brazilian HIV Patients
Carlos Brites, Roberta Schiavon Nogueira, Gisele Cristina Gosuen, et al.
AIDS Research and Human Retroviruses (2019) Vol. 35, Iss. 11-12, pp. 1103-1105
Closed Access | Times Cited: 8

Prevalence of polypharmacy and associated factors among patients living with HIV infection in Spain: The POINT study
Ramón Morillo‐Verdugo, J Sánchez-Rubio-Ferrández, Mercedes Gimeno-Gracia, et al.
Enfermedades Infecciosas y Microbiología Clínica (2020) Vol. 40, Iss. 1, pp. 7-13
Closed Access | Times Cited: 7

Clinical Relevance of Drug Interactions in People Living with Human Immunodeficiency Virus on Antiretroviral Therapy—Update 2022: Systematic Review
Pedro Amariles, Mónica Rivera-Cadavid, Mauricio Ceballos
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2488-2488
Open Access | Times Cited: 2

THE IMPACT OF INFLAMMATION AND DRUG INTERACTIONS ON COVID-19 PHARMACOTHERAPY. A MINI-REVIEW
MONICA NEAMȚU
FARMACIA (2022) Vol. 70, Iss. 5, pp. 775-784
Open Access | Times Cited: 4

Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa
Nomcebo Oratile Mokgethi, Nicola Christofides, Mercilene Machisa, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 3

Drug-Related Problems in HIV Treatment Failure
Mohd Farizh Che Pa, Ng Tiang Koi, Arisah Misnan, et al.
Cureus (2024)
Open Access

Antiviral Drugs
Sreekumar Othumpangat, John D. Noti
Side effects of drugs annual (2018), pp. 345-361
Closed Access | Times Cited: 2

Prevalence of polypharmacy and associated factors among patients living with HIV infection in Spain: The POINT study
Ramón Morillo‐Verdugo, J Sánchez-Rubio-Ferrández, Mercedes Gimeno-Gracia, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2022) Vol. 40, Iss. 1, pp. 7-13
Closed Access | Times Cited: 1

Page 1

Scroll to top